Helen Mackay

1 ta ish

University Health Network

1. Phase II study of temsirolimus (CCI-779) in women with recurrent, unresectable, locally advanced or metastatic carcinoma of the cervix. A trial of the NCIC Clinical Trials Group (NCIC CTG IND 199)

   Anna V. Tinker, Susan Ellard, Stephen Welch +7

   Maqola20132 iqtibos

   ABIABI:AkademIndex/2026.other.002971